CUP:FRA
Chugai Pharmaceutical Co Ltd
€40.48
0.00%
(0.00) 1D
Nov 11, 3:25:02 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUP...
Mkt. cap
12.00T
Avg. vol.
10.00
Volume
0.00
52-wk high
€56.26
52-wk low
€33.52
No. of employees
5K
Mkt. cap
12.00T
Avg. vol.
10.00
Volume
0.00
52-wk high
€56.26
52-wk low
€33.52
No. of employees
5K
News stories
From web sources and news partners
TradingView
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
FOREX.com
·
13 hours ago
S&P 500 Forecast: SPX rebounds amid revived AI enthusiasm
Eurasia Business News
·
11 hours ago
Stock Market Today: Dow Jones, Nasdaq, S&P 500 Rally on November 11, 2026; Oil Rises, Gold Slips
Traders Union
·
9 hours ago
Peter Tuchman: S&P 500 gains over $900 billion in market cap, closing up 1.3 percent
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitechugai-pharm.co.jp